ALB and Alzheimer disease: Furthermore, they also looked at the presence of albumin in the CSF and found that sPDGFRβ levels correlated with albumin ones in CSF samples [30] (Table 2); therefore, this may be indicating that levels of both markers in the CSF can be used as a rate of cerebrovascular damage and/or its progression in AD.